Why the Prostate Cancer Screening Controversy?
The prostate cancer testing method, the PSA test, is not always a reliable indication for the presence of prostate cancer – it can result in a large number of false positives, with over 60% of men who show raised PSA scores not actually having prostate cancer. Other factors that may contribute to a raised PSA score include infection or inflammation of the prostate or benign prostatic hyperplasia (BPH) – an enlargement of the prostate that is not cancerous. In addition, PSA levels generally rise as men get older, thus contributing to a higher PSA score. Scientists are working to improve the PSA test and also to identify other molecular markers to improve screening for prostate cancer, as current prostate cancer testing methods may lead to many men undergoing biopsies unnecessarily. document.getElementById(‘adsense_placeholder_2’).innerHTML = document.getElementById(‘adsense_ad_2_hidden’).innerHTML; Prostate cancer screening may also result in many diagnosed patients being treated premat